ILifeLink

Company Description

LifeLink was founded in 1992 by David Blanco to bring cutting-edge biologics to people with life-threatening diseases (LTDs). Among these compounds ILifeLinkre several attention-getters, such as the TAT inhibitor, phthalimidoglutarimide, and DHEA. (See articles in the Los Angeles Daily News, June 5, 1994; Wall Street Journal, June 2, 1995; The Bergen Record, December 28, 1995; and Newsweek, September 16, 1996.)